Osaic Holdings’s Cryo-Cell International CCEL Stock Holding History

Osaic Holdings’s Portfolio CCEL Stock Details CCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.97K	Hold	2,500	–	–	﹤0.01%	6725
2026 Q1	$8.88K	Hold	2,500	–	–	﹤0.01%	6373
2025 Q4	$8.6K	Hold	2,500	–	–	﹤0.01%	6434
2025 Q3	$11.8K	Sell	2,500 -744	-23%	-$3.53K	﹤0.01%	6266
2025 Q2	$16.8K	Sell	3,244 -201	-6%	-$1.06K	﹤0.01%	5836
2025 Q1	$21.9K	Buy	3,445 +1,445	+72%	+$10.5K	﹤0.01%	5295
2024 Q4	$14.8K	Hold	2,000	–	–	﹤0.01%	5536
2024 Q3	$12.7K	Hold	2,000	–	–	﹤0.01%	5661
2024 Q2	$15.2K	Sell	2,000 -500	-20%	-$4.14K	﹤0.01%	5525
2024 Q1	$18.6K	Hold	2,500	–	–	﹤0.01%	5411
2023 Q4	$14.4K	Sell	2,500 -2,000	-44%	-$10.4K	﹤0.01%	5655
2023 Q3	$23.7K	Buy	4,500 +2,000	+80%	+$11.7K	﹤0.01%	5459
2023 Q2	$15.2K	Hold	2,500	–	–	﹤0.01%	5736
2023 Q1	$7.55K	Buy	2,500 +500	+25%	+$1.93K	﹤0.01%	6136
2022 Q4	$8K	Hold	2,000	–	–	﹤0.01%	6055
2022 Q3	$12K	Hold	2,000	–	–	﹤0.01%	5907
2022 Q2	$12K	Hold	2,000	–	–	﹤0.01%	5949
2022 Q1	$15K	Buy	+2,000	New	+$18.5K	﹤0.01%	5870

Other funds holding CCEL

SFI Advisors Montclair, New Jersey $116M AUM 37.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings's CCEL Position: Q2 2026 in Review

Osaic Holdings held its Cryo-Cell International (CCEL) position steady in Q2 2026 at 2,500 shares worth $7.97K. The position accounts for ﹤0.01% of the portfolio, ranked #6725.

Osaic Holdings first reported a position in CCEL in Q1 2022 and has held it in 18 quarters since. The position peaked at $23.7K in Q3 2023. 12 funds tracked by Wall St. Rank hold CCEL as of Q2 2026.

Osaic Holdings held 2,500 shares of Cryo-Cell International worth $7.97K as of Q2 2026.
Osaic Holdings left its Cryo-Cell International share count unchanged in Q2 2026.
Cryo-Cell International made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6725 holding.
Osaic Holdings first reported a position in Cryo-Cell International in Q1 2022 and has held it in 18 quarters since.
Osaic Holdings's Cryo-Cell International position peaked at $23.7K in Q3 2023.
12 funds tracked by Wall St. Rank held Cryo-Cell International as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.